Hospitalizations in Infants and Young Children With Cystic Fibrosis Enrolled in Medicaid
Pediatric Pulmonology · 2025
DOI: 10.1002/ppul.71302 ↗At a glance
Journal article in Pediatric Pulmonology, 2025. Written by Laurie P Murray and 5 co-authors. Institution: Division of Pulmonary and Sleep Medicine, Department of Pediatrics, Columbia University Irving Medical Center, New York, USA. Major MEDLINE topics: Medicaid, Cystic Fibrosis, Hospitalization, Respiratory Syncytial Virus Infections. 30 references. Funded by: Laurie Murray was supported by the NIH T32 Grant: Training in Pediatric Infectious Diseases 2T32AI0007531-21. PI: Lisa Saiman..
Topics: Kinderkrankenpflege
Abstract (original language)
Background
There are limited data describing hospitalization rates among infants and young children with CF (cwCF). National administrative claims databases can be used to characterize hospitalizations among cwCF which could inform the future impact of novel therapies increasingly being integrated into routine care for cwCF.
Methods
We performed a retrospective cohort study of the Merative Medicaid Marketscan database from 2010 to 2019 to characterize hospitalizations among cwCF during their first 3 calendar‐years of life. Eligible cwCF were identified using International Classification of Diseases 9/10 codes and had a pharmacy fill for pancreatic enzymes. Hospitalizations were categorized as complicated neonatal, respiratory, gastrointestinal, or other types using Diagnosis Related Groups (DRG).
Results
During the study period, 518 (62.7%) of unique cwCF were hospitalized, amounting to an overall hospitalization rate of 70.9 (95% CI: 67.0–75.0) per 100 child‐years. In the birth year complicated neonatal DRGs were most common while in the second and third calendar‐years respiratory DRGs were most common. In the second calendar‐year of life, respiratory syncytial virus (RSV) and influenza were identified in 11.1% and 6.8% of respiratory hospitalizations, respectively.
Conclusions
CwCF experienced a large burden of hospitalizations during their first three calendar‐years of life. Respiratory DRGs were most common in the second and third calendar‐years and included a substantial proportion of RSV‐ and influenza‐associated hospitalizations. Such data can inform future work assessing the impact of new therapies for CF and RSV.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Division of Pulmonary and Sleep Medicine, Department of Pediatrics, Columbia University Irving Medical Center, New York, USA.
- Children's Hospital Association, Lenexa, USA.
- Division of Pulmonary and Sleep Medicine, Department of Pediatrics, University of Washington, Seattle, USA.
- Division of Pediatric Infectious Disease, Department of Pediatrics, Columbia University Irving Medical Center, New York, USA.
- Department of Infection Prevention and Control, NewYork-Presbyterian Hospital, New York, USA.
ORCID profiles: Laurie P Murray, Jonathan D Cogen, Hossein Sadeghi
Funding
- Laurie Murray was supported by the NIH T32 Grant: Training in Pediatric Infectious Diseases 2T32AI0007531-21. PI: Lisa Saiman.
Cite
APA
Murray, L. P., Zamani, M., Cogen, J. D., Hall, M., Sadeghi, H., & Saiman, L. (2025). Hospitalizations in Infants and Young Children With Cystic Fibrosis Enrolled in Medicaid. Pediatric Pulmonology. https://doi.org/10.1002/ppul.71302
Vancouver
Murray LP, Zamani M, Cogen JD, Hall M, Sadeghi H, Saiman L. Hospitalizations in Infants and Young Children With Cystic Fibrosis Enrolled in Medicaid. Pediatric Pulmonology. 2025. doi:10.1002/ppul.71302
BibTeX
@article{Murray2025,
author = {Murray, Laurie P and Zamani, Mark and Cogen, Jonathan D and Hall, Matt and Sadeghi, Hossein and Saiman, Lisa},
title = {Hospitalizations in Infants and Young Children With Cystic Fibrosis Enrolled in Medicaid},
journal = {Pediatric Pulmonology},
year = {2025},
doi = {10.1002/ppul.71302}
}
EUVIMED